Eliem Therapeutics Inc
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Market Cap & Net Worth: Eliem Therapeutics Inc (ELYM)
Eliem Therapeutics Inc (NASDAQ:ELYM) has a market capitalization of $207.22 Million ($207.22 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #19113 globally and #7046 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eliem Therapeutics Inc's stock price $3.09 by its total outstanding shares 67060200 (67.06 Million).
Eliem Therapeutics Inc Market Cap History: 2021 to 2024
Eliem Therapeutics Inc's market capitalization history from 2021 to 2024. Data shows change from $701.45 Million to $207.22 Million (-38.94% CAGR).
Index Memberships
Eliem Therapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1755 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.54 Trillion | 0.01% | #234 of 263 |
Weight: Eliem Therapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Eliem Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eliem Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ELYM by Market Capitalization
Companies near Eliem Therapeutics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Eliem Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Eliem Therapeutics Inc Historical Marketcap From 2021 to 2024
Between 2021 and today, Eliem Therapeutics Inc's market cap moved from $701.45 Million to $ 207.22 Million, with a yearly change of -38.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $207.22 Million | +14.44% |
| 2023 | $181.06 Million | -26.43% |
| 2022 | $246.11 Million | -64.91% |
| 2021 | $701.45 Million | -- |
End of Day Market Cap According to Different Sources
On Dec 3rd, 2025 the market cap of Eliem Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $207.22 Million USD |
| MoneyControl | $207.22 Million USD |
| MarketWatch | $207.22 Million USD |
| marketcap.company | $207.22 Million USD |
| Reuters | $207.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.